由于特种药品销售强, GSK报告第一季度净利增长7%. GSK reported a 7% increase in first-quarter net profit driven by strong specialty medicine sales.

英国制药公司GSK报告第一季度净利增长7%,达到17亿英,主要原因是特种药品的销售强. British pharmaceutical company GSK reported a 7% increase in first-quarter net profit to £1.7 billion, driven by strong sales of specialty medicines. 公司收入达到76亿英,增长2%,超过分析师对每股收益的预期. Revenue reached £7.6 billion, up 2%, surpassing analyst expectations for earnings per share. 公司重申了2026年全年的预期,并预计核心营业利和收益将增长7%至9%. The company reaffirmed its full-year 2026 guidance, projecting core operating profit and earnings growth of 7% to 9%.